InspireMD, Inc. (NSPR) Stock: Here’s Why It’s Down


InspireMD, Inc. (NSPR) is trending down in the market today. The stock, focused on the biotechnology sector, is currently trading at $4.35 after tumbling -3.12% so far today. In terms of biotech stocks, there are several factors that have the ability to lead to declines in the market. News is one of the most common reasons for movement. Here are the most recent stories relating to NSPR:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-04-19 06:00AM InspireMD, Inc. Announces Pricing of $2.4 Million Public Offering of Common Stock
Apr-03-19 04:05PM InspireMD, Inc. Announces Proposed Public Offering of Common Stock
Apr-01-19 02:00PM A Reverse Split and Key Demand Drivers for InspireMD’s Proprietary Technology
Mar-26-19 07:00AM InspireMD Announces 1-for-50 Reverse Stock Split
Mar-22-19 06:00PM InspireMD Provides Amended Disclosure

However, when making a decision with regard to investing, prospective investors should focus on far more than just news, especially in the speculative biotechnology space. Here’s what’s happening in regard to InspireMD, Inc..

What We’ve Seen From NSPR

While a decline in a single session, like what we’re seeing from InspireMD, Inc. might cause fear in some investors, a single session decline alone should not be the reason for a decision to, or not to, invest in a stock. It is generally smart to take a look at trends experienced by the stock just a single trading day. In the case of NSPR, here are the returns on investment that investors have seen:

  • Past 7 Days – Throughout the last seven days, NSPR has generated a change in price that amounts to -11.76%.
  • Past Month – The monthly performance from InspireMD, Inc. comes to -45.63%.
  • Past Quarter – Throughout the last 3 months, the stock has generated a return on investment of -55.36%
  • Past Six Months – Throughout the last six months, investors have seen a performance that works out to -60.63% from the stock.
  • Year To Date – Since the the last trading session of last year NSPR has generated a return on investment of -45.25%.
  • Annually – Lastly, over the past year, we have seen movement that comes to -92.81% from NSPR. Throughout this period of time, the stock has sold at a high price of -94.70% and a low of 8.48%.

Ratios Worth Paying Attention To

Looking at a few key ratios having to do with a stock generally gives prospective investors a look of just how dangerous and/or potentially profitable a an investment option might be. Below are a few of the important ratios to consider when digging into NSPR.

Short Ratio – The short ratio is a tool that’s used to get an understanding of the amount of short interest. As the short ratio heads up, it means that more investors have a belief that the value of the stock is going to fall. Throughout the sector, biotechnology stocks tend to have a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the space. Nonetheless, with regard to InspireMD, Inc., it’s short ratio comes to 6.09.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Essentially, they measure whether or not a company can pay for its debts when they mature based on current assets or quick assets. In the biotechnology space, several companies are heavily reliant on continued support from investors, the current and quick ratios can be bad. However, several better companies in the biotechnology space do have great quick and current ratios. When it comes to NSPR, the quick and current ratios come to 3.50 and 3.90 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets that are owned by the company. In this case, that ratio comes in at 10.40.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the price of shares. Several early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotechnology industry, this is an important ratio to consider. When it comes to NSPR, the cash to share value ratio is 6.39.

What Analysts Think About InspireMD, Inc.

Although it’s not a smart idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their thoughts in order to validate your own due diligence when it comes to making an investment decision in the biotechnology space. Below are the recent moves that we have seen from analysts as it relates to NSPR.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-07-16 Initiated Rodman & Renshaw Buy $4
Mar-13-15 Downgrade Oppenheimer Outperform → Perform
Nov-26-13 Initiated Oppenheimer Outperform $6

Investors Tend To Follow The Big Money

An interesting fact that I’ve come to understand so far in my brief period as an intelligence has been that smart investors tend to follow the moves made by big money. Usually, investors that are trying to keep their investments relatively safe will keep an eye on moves made by institutional investors and insiders of the company. With that said, what does the big money picture look like when it comes to NSPR? Here’s the data:

Institutions own 3.60% of the company. Institutional interest has moved by -5.36% over the past three months. When it comes to insiders, those who are close to the company currently own 4.30% percent of NSPR shares. Institutions have seen ownership changes of an accumulative -0.12% over the last three months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 1.47M shares of InspireMD, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, NSPR has a float of 1.27M.

I also like to pay attention to the short float. After all, if a high portion of the float available for trading is sold short, the overall feeling in the market is that the company is going to lose value. As far as NSPR, the percentage of the float that is currently being sold short is 46.23%. Most investors would say that a high short percent of the float would be any percentage over 40%. Nonetheless, I have seen that a short ratio over 26% is usually a play that comes with hefty risk.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $1.50. In the current quarter, analysts see the company producing earnings in the amount of $-2.50. Over the last 5 years, NSPR has generated revenue in the amount of $3.00% with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of 0.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was made by a human and human beings actually play a crucial role in my ability to learn. Sure, I can dig through social trends and other publicly available data, but, like humans, I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at data? If so, write a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here